Effects of the immunosuppressant cyclosporin A on neurotransmitter release from peripheral non-adrenergic, non-cholinergic nerves

Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):398-403. doi: 10.1007/pl00005068.

Abstract

This study was undertaken to determine the effect of the immunosuppressant cyclosporin A on neurotransmitter release from non-adrenergic, non-cholinergic nerves (tachykininergic nerves) in the rabbit iris sphincter muscle. Cumulative application of cyclosporin A (0.1 to 10 microM) caused a slow onset of contraction in a concentration-dependent manner. Both FK888 (1 microM) and capsaicin (10 microM), a substance P receptor antagonist and a substance P-depleting agent, respectively, inhibited the contractile effect of cyclosporin A, whereas atropine (1 microM) had no effect. Both cyclosporin A and capsaicin (10 microM) stimulated the release of substance P-like immunoreactivity in the iris. Neither the sodium channel blocker tetrodotoxin (1 microM), the N-type voltage-dependent Ca2+ channel blocker omega-conotoxin GVIA (1 microM) nor the P-type channel blocker omega-agatoxin IVA (0.2 microM) affected cyclosporin A (1 microM)-induced contraction. In contrast, the L-type Ca2+ channel blocker nicardipine (10 microM) inhibited this contractile effect. These results suggest that cyclosporin A stimulates substance P-like tachykinin release by activating L-type voltage-dependent Ca2+ channels, resulting in contraction of the rabbit iris sphincter muscle.

MeSH terms

  • Animals
  • Atropine / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Capsaicin / pharmacology
  • Cyclosporine / pharmacology*
  • Dipeptides / pharmacology
  • Immunosuppressive Agents / pharmacology*
  • Indoles / pharmacology
  • Iris / drug effects
  • Iris / innervation*
  • Iris / metabolism
  • Male
  • Muscarinic Antagonists / pharmacology
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / innervation*
  • Muscle, Smooth / metabolism
  • Nerve Fibers / metabolism*
  • Neurokinin-1 Receptor Antagonists
  • Rabbits
  • Sodium Channel Blockers
  • Substance P / metabolism*

Substances

  • Calcium Channel Blockers
  • Dipeptides
  • Immunosuppressive Agents
  • Indoles
  • Muscarinic Antagonists
  • Neurokinin-1 Receptor Antagonists
  • Sodium Channel Blockers
  • FK 888
  • Substance P
  • Atropine
  • Cyclosporine
  • Capsaicin